Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Wagner

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Discover Oncology|April 19, 2025
Histopathological biomarkers in squamous cell carcinoma of the vulva: the prognostic relevance of tumor-infiltrating lymphocytes (TILs)-a retrospective study of 157 casesGilbert Georg Klamminger, Meletios P Nigdelis, Yaman Degirmenci, et al.
The Journal of Surgical Research|March 26, 2011
Split-liver procedure and inflammatory response: improvement by pharmacological preconditioningMaximilian von Heesen, Matthias Hülser, Katharina Seibert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancerBoris Kubuschok, Frank Neumann, Rainer Breit, et al.
Cancer Cytopathology|February 8, 2024
Prediction of lymph node status in patients with surgically treated head and neck squamous cell carcinoma via neck lavage cytology: A pilot studyHugo Rimbach, Maximilian Linxweiler, Sandrina Körner, et al.
Cancers|January 11, 2024
Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary ChemoradiationMaximilian Linxweiler, Matthias Schneider, Sandrina Körner, et al.
International Journal of Molecular Sciences|December 9, 2023
HLA-E and Its Soluble Form as Indicators of a Sex-Specific Immune Response in Patients with Oral Squamous Cell CarcinomaAnne Radermacher, Michael Fehrenz, Tamara Bellin, et al.
Molecular Diagnosis & Therapy|November 1, 2024
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient CohortMaximilian Linxweiler, Silke Wemmert, Felix Leon Braun, et al.
The International Journal of Biological Markers|July 26, 2022
Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patientsJan Philipp Kühn, Florian Bochen, Sandrina Körner, et al.
Cancer Medicine|August 23, 2025
ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective StudyMeletios P Nigdelis, Annick Bitterlich, Mariam Parvanta, et al.
Cancer Medicine|April 13, 2026
Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland CarcinomasLukas A Brust, Jan Philipp Kühn, Sandrina Körner, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Discover Oncology|April 19, 2025
Histopathological biomarkers in squamous cell carcinoma of the vulva: the prognostic relevance of tumor-infiltrating lymphocytes (TILs)-a retrospective study of 157 casesGilbert Georg Klamminger, Meletios P Nigdelis, Yaman Degirmenci, et al.
The Journal of Surgical Research|March 26, 2011
Split-liver procedure and inflammatory response: improvement by pharmacological preconditioningMaximilian von Heesen, Matthias Hülser, Katharina Seibert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancerBoris Kubuschok, Frank Neumann, Rainer Breit, et al.
Cancer Cytopathology|February 8, 2024
Prediction of lymph node status in patients with surgically treated head and neck squamous cell carcinoma via neck lavage cytology: A pilot studyHugo Rimbach, Maximilian Linxweiler, Sandrina Körner, et al.
Cancers|January 11, 2024
Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary ChemoradiationMaximilian Linxweiler, Matthias Schneider, Sandrina Körner, et al.
International Journal of Molecular Sciences|December 9, 2023
HLA-E and Its Soluble Form as Indicators of a Sex-Specific Immune Response in Patients with Oral Squamous Cell CarcinomaAnne Radermacher, Michael Fehrenz, Tamara Bellin, et al.
Molecular Diagnosis & Therapy|November 1, 2024
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient CohortMaximilian Linxweiler, Silke Wemmert, Felix Leon Braun, et al.
The International Journal of Biological Markers|July 26, 2022
Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patientsJan Philipp Kühn, Florian Bochen, Sandrina Körner, et al.
Cancer Medicine|August 23, 2025
ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective StudyMeletios P Nigdelis, Annick Bitterlich, Mariam Parvanta, et al.
Cancer Medicine|April 13, 2026
Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland CarcinomasLukas A Brust, Jan Philipp Kühn, Sandrina Körner, et al.
Pageof 13